Insider · CIK 0001595064

Richardson Linda M

Reports to the SEC for 3 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001595064

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	ALTAltimmune, Inc.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+24K sh	—	—	24,000
2026-09-16	ALTAltimmune, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−6,826 sh	$3.24	−$22.1K	17,174
2026-09-16	ALTAltimmune, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−24K sh	—	—	72,000
2025-09-16	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Chief Commercial Officer	AAward	+278K sh	—	—	278,000
2025-09-16	ALTAltimmune, Inc. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+96K sh	—	—	96,000
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	EVP & Chief Commercial Officer	UDisposition from Tender	−16.7K sh	$19.00	−$317K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−26.6K sh	$19.00	−$505K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−17.6K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−20K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−3,912 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−8,368 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−5,896 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−9,500 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	EVP & Chief Commercial Officer	DDisposition to Issuer	−8,500 sh	—	—	0
2023-02-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−386 sh	$21.21	−$8,187.06	43,291
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	EVP & Chief Commercial Officer	AAward	+12.2K sh	—	—	43,677
2023-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	EVP & Chief Commercial Officer	AAward	+20K sh	—	—	20,000
2022-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−1,600 sh	$12.37	−$19.8K	31,477
2022-09-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−597 sh	$18.06	−$10.8K	33,077
2022-08-15	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−124 sh	$18.19	−$2,255.56	33,674
2022-05-15	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−124 sh	$17.88	−$2,217.12	33,798
2022-02-15	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−171 sh	$15.93	−$2,724.03	33,922
2022-02-14	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−529 sh	$14.85	−$7,855.65	34,093
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.A Award	EVP & Chief Commercial Officer	AAward	+10.3K sh	—	—	34,622
2022-01-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	EVP & Chief Commercial Officer	AAward	+17.6K sh	—	—	17,600
2021-12-31	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−1,211 sh	$16.29	−$19.7K	24,322
2021-11-15	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−171 sh	$17.67	−$3,021.57	25,533
2021-09-01	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−820 sh	$15.05	−$12.3K	25,704
2021-08-15	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−171 sh	$14.92	−$2,551.32	26,524
2021-05-15	INTERCEPT PHARMACEUTICALS, INC.F Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−171 sh	$18.15	−$3,103.65	26,695
2021-02-15	INTERCEPT PHARMACEUTICALS, INC.A Award	EVP & Chief Commercial Officer	AAward	+5,531 sh	—	—	26,866
2021-02-15	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	EVP & Chief Commercial Officer	AAward	+8,500 sh	—	—	8,500
2018-05-14	CHIMERIX INCF Tax Payment	Chief Commercial Officer	FTax Payment	−4,545 sh	$4.66	−$21.2K	54,161
2018-02-02	CHIMERIX INCF Tax Payment	Chief Commercial Officer	FTax Payment	−2,290 sh	$4.67	−$10.7K	58,706
2018-01-25	CHIMERIX INCStock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+135K sh	—	—	135,000
2017-12-01	CHIMERIX INCS Sale	Chief Commercial Officer	SSale	−19.8K sh	$4.47	−$88.7K	60,996
2017-05-12	CHIMERIX INCF Tax Payment	Chief Commercial Officer	FTax Payment	−10.2K sh	$4.68	−$47.6K	80,829
2017-01-24	CHIMERIX INCA Award	Chief Commercial Officer	AAward	+30.4K sh	—	—	90,996
2017-01-24	CHIMERIX INCStock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+60.8K sh	—	—	60,750
2016-05-09	CHIMERIX INCA Award	Chief Commercial Officer	AAward	+60K sh	—	—	60,621
2016-01-08	CHIMERIX INCStock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+178K sh	—	—	178,000
2015-01-28	CHIMERIX INCStock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+65K sh	—	—	65,000
2014-01-08	CHIMERIX INCStock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+120K sh	—	—	120,000

Recent filings

Accepted (ET)
Sep 174
Richardson Linda M0001595064-26-000002
SEC(opens sec.gov)
Sep 174
Richardson Linda M0001104659-25-090867
SEC(opens sec.gov)
Nov 134
Richardson Linda M0001104659-23-117112
SEC(opens sec.gov)
Feb 164
Richardson Linda M0001104659-23-022788
SEC(opens sec.gov)
Jan 314
Richardson Linda M0001104659-23-008586
SEC(opens sec.gov)
Jan 34
Richardson Linda M0001104659-23-000335
SEC(opens sec.gov)
Sep 64
Richardson Linda M0001104659-22-097842
SEC(opens sec.gov)

Companies

Address

910 CLOPPER ROAD SUITE 201S

GAITHERSBURG, MD, 20878